Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older
Author(s) -
Ariela R. Orkaby,
Jane A. Driver,
YukLam Ho,
Bing Lü,
Lauren Costa,
Jacqueline Honerlaw,
Ashley Galloway,
Jason L. Vassy,
Daniel E. Forman,
J. Michael Gaziano,
David R. Gag,
Peter W.F. Wilson,
Kelly Cho,
Luc Djoussé
Publication year - 2020
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2020.7848
Subject(s) - medicine , statin , percutaneous coronary intervention , retrospective cohort study , stroke (engine) , myocardial infarction , coronary artery disease , veterans affairs , propensity score matching , revascularization , proportional hazards model , medical prescription , emergency medicine , physical therapy , mechanical engineering , engineering , pharmacology
Data are limited regarding statin therapy for primary prevention of atherosclerotic cardiovascular disease (ASCVD) in adults 75 years and older.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom